CPHI China 2025 zai gudana daga Yuni 24-26, 2025, a Shanghai New International Expo Center (SNIEC). Fiye da murabba'in murabba'in mita 230,000, an saita taron don ɗaukar nauyin masu baje kolin 3,500 kuma ya jawo hankalin ƙwararrun masana'antu sama da 100,000. A matsayin daya daga cikin manyan kasuwancin harhada magunguna mafi girma da tasiri a Asiya, CPHI ta kasar Sin tana ba da wani dandali da ba zai misaltu ba don hada kai, kirkire-kirkire, da bunkasuwar kasuwanci.
 
Game da JYMed
 
JYMed babban kamfani ne na samar da magunguna da ke mayar da hankali kan bincike, haɓakawa, masana'antu, da kasuwancin samfuran tushen peptide. Har ila yau, muna ba da cikakkiyar sabis na CDMO mai haɗaka, yana isar da ingantattun hanyoyin peptide ga magunguna, kayan kwalliya, da abokan cinikin dabbobi a duk duniya.
 
Fayil ɗin samfurin mu ya haɗa da dozin na peptide APIs. Kayayyakin tuta irin su Semaglutide da Tirzepatide sun yi nasarar kammala shigar da FDA DMF ta Amurka.

Reshen mallakarmu gabaɗaya, Hubei JXBio, yana gudanar da layukan samar da peptide API na zamani wanda aka gina don saduwa da ƙa'idodin cGMP waɗanda FDA ta Amurka da NMPA ta China suka tsara. Wurin yana dauke da manyan layukan samar da sikeli guda 10 da matukin jirgi, wanda ke samun goyan bayan ingantaccen Tsarin Gudanar da Ingancin Magunguna (QMS) da kuma cikakken shirin Lafiya da Tsaro na Muhalli (EHS).
 
JXBio ya wuce binciken GMP ta hanyar FDA ta Amurka da NMPA na kasar Sin kuma manyan kamfanonin harhada magunguna na duniya sun amince da su don nagarta a gudanar da EHS, yana nuna himma ga inganci, aminci, da kula da muhalli.

BABBAN KAYANA

Tuntube Mu

Don ƙarin bayani game da samfuranmu da ayyukanmu, da fatan za a tuntuɓi:
● API na Duniya & Tambayoyin Kayan Kayan Aiki:+ 86-150-1352-9272
● Rijistar API & Ayyukan CDMO (Amurka & EU):+ 86-158-1868-2250
● Imel: jymed@jymedtech.com
● Adireshi:benaye 8 & 9, Ginin 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen, China.